Q3 2025 Holdings
Filed 2025-11-13 | 9 holdings | $16.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ovid Therapeutics, Inc.(OVID) | COM | 690469101 | $9.8M | 7,531,996 | 59.8% |
| Equillium, Inc.(EQ) | COM | 29446K106 | $2.6M | 1,824,977 | 15.9% |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)(XLO) | COM | 98422T100 | $1.2M | 1,475,121 | 7.6% |
| Shattuck Labs, Inc.(STTK) | COM | 82024L103 | $1.2M | 515,619 | 7.5% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $891.4K | 54,887 | 5.4% |
| American Well Corporation(AMWL) | COM | 03044L204 | $478.1K | 77,733 | 2.9% |
| Rani Therapeutics Holdings, Inc.(RANI) | COM | 753018100 | $101.6K | 203,190 | 0.6% |
| Standard Biotools, Inc.(LAB) | COM | 34385P108 | $21.5K | 16,515 | 0.1% |